High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

por Ishikawa K, Nagai T, Tsuchiya K, Oshita Y, Kuroda T, Ito H, Tani S, Dodo Y, Toyone T, Inagaki K
Publicado 2018

Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopaus...

por Tsuchiya K, Ishikawa K, Tani S, Oshita Y, Kuroda T, Yamamura R, Emori H, Maruyama H, Matsuoka A, Kudo Y, Shirahata T, Toyone T, Nagai T, Inagaki K
Publicado 2019